You are here: Industry Insights > biological

News List

FDA Finalizes Guidance with Internationally Harmonized Recommendations to Further Support Safe, High-Quality Human Drug Products americanpharmaceuticalreview
May 14, 2021
The U.S. Food and Drug Administration is announcing the availability of a final guidance for industry, “Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management.”
Avomeen Appoints Project Director of Biological Chemistry contractpharma
August 12, 2019
In this newly created position, Courtney will help grow Avomeen’s large-molecule and protein therapeutics business segment.
Emerging NMR techniques as advanced tools for characterising biological parenteral products europeanpharmaceuticalreview
May 21, 2019
Emerging NMR techniques as advanced tools for characterising biological parenteral products.
Lonza Pharma&Biotech Launches Ibex™ Solutions – An Innovative New Concept in Biological Manufacturing and Development europeanpharmaceuticalreview
May 07, 2019
Lonza’s commitment to constant innovation and adding value to its customers and partners is today demonstrated by the launch of Ibex™ Solutions – a unique addition to its current offering…
3D printing technique creates super soft biological structures europeanpharmaceuticalreview
April 30, 2019
A new 3D printing technique allows researchers to replicate biological structures, which could be used for tissue regeneration and replica organs…
FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor's office or clinic worldpharmanews
March 07, 2019
The U.S. Food and Drug Administration (FDA) today approved Spravato (esketamine) nasal spray
New microscope offers options for drug discovery, safety europeanpharmaceuticalreview
March 06, 2019
Researchers have developed a microscope that may provide insight into how safely and effectively a drug will perform in the body…
Analysis of Global Biological Drugs Marketed in 2009-2018 from Type, Region, and Therapeutic Area (2) PharmaSources/Xuanyao
February 25, 2019
Distribution of Top 10 Types of Global Biological Drugs Marketed in Recent Decade;Distribution of Top 10 Therapeutic Areas of Global Biological Drugs Marketed in Recent Decade.
Japanese telecom giant injects $1.1bn into Swiss biotech in largest-ever investment of its kind pharmafile
August 11, 2017
In possibly the biggest single biotech investment ever made, Swiss biotech firm Roivant has received a $1.1 billion cash injection thanks to an investment from Japanese telecom giant SoftBank.
SynBio: unlocking the commercial potential of a new bioscience industry europeanpharmaceuticalreview
August 09, 2017
An exclusive column from the ABPI’s Magda Papadaki about the implications of synthetic biology for the pharmaceutical industry

Previous page 1 2 Next page